GOLPH3 Predicts Survival of Colorectal Cancer Patients Treated With 5-Fluorouracil-Based Adjuvant Chemotherapy

Journal of Translational Medicine - United Kingdom
doi 10.1186/1479-5876-12-15
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Thymidylate Synthase Gene Polymorphism Predicts Toxicity in Colorectal Cancer Patients Receiving 5-Fluorouracil-Based Chemotherapy

Clinical Cancer Research
Cancer ResearchOncology
2004English

Predicting the Effect of 5-Fluorouracil-Based Adjuvant Chemotherapy on Colorectal Cancer Recurrence: A Model Using Gene Expression Profiles

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2020English

P53 Expression Status Is Associated With Cancer-Specific Survival in Stage III and High-Risk Stage II Colorectal Cancer Patients Treated With Oxaliplatin-Based Adjuvant Chemotherapy

British Journal of Cancer
Cancer ResearchOncology
2019English

Evaluation of the 5‑fluorouracil Plasma Level in Patients With Colorectal Cancer Undergoing Continuous Infusion Chemotherapy

Molecular and Clinical Oncology
Cancer ResearchOncology
2019English

Adjuvant Chemotherapy of Colorectal Cancer

Oncologist
Cancer ResearchMedicineOncology
1996English

Comparison of Adverse Events During 5-Fluorouracil Versus 5-Fluorouracil/Oxaliplatin Adjuvant Chemotherapy for Stage III Colon Cancer

Cancer
Cancer ResearchOncology
2012English

Hypertension and Overall Survival in Metastatic Colorectal Cancer Patients Treated With Bevacizumab-Containing Chemotherapy

British Journal of Cancer
Cancer ResearchOncology
2011English

Polo-Like Kinase 2 Promotes Chemoresistance and Predicts Limited Survival Benefit From Adjuvant Chemotherapy in Colorectal Cancer

International Journal of Oncology
Cancer ResearchOncology
2018English

Pretreatment Immune Status Correlates With Progression-Free Survival in Chemotherapy-Treated Metastatic Colorectal Cancer Patients

Cancer immunology research
Cancer ResearchImmunology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy